Ownership history in Opaleye Management Inc. · 16 quarters on record
This page tracks every 13F SEC filing in which Opaleye Management Inc. reported a position in ADAMAS PHARMACEUTICALS INC (ADMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2021 Q3 | REDUCED | 1,460,000 | -210,600 | -12.6% | 1.34% | $7.2M | — |
| 2021 Q2 | UNCHANGED | 1,670,600 | — | 0% | 1.47% | $8.8M | — |
| 2021 Q1 | ADDED | 1,670,600 | +182,800 | +12.3% | 1.18% | $8.0M | — |
| 2020 Q4 | UNCHANGED | 1,487,800 | — | 0% | 0.84% | $6.4M | — |
| 2020 Q3 | ADDED | 1,487,800 | +527,800 | +55.0% | 1.20% | $6.1M | — |
| 2020 Q2 | ADDED | 960,000 | +670,000 | +231.0% | 0.50% | $2.5M | — |
| 2017 Q2 | UNCHANGED | 290,000 | — | 0% | 2.12% | $5.1M | — |
| 2017 Q1 | ADDED | 290,000 | +5,000 | +1.8% | 2.53% | $5.1M | — |
| 2016 Q4 | ADDED | 285,000 | +35,000 | +14.0% | 2.84% | $4.8M | — |
| 2016 Q3 | REDUCED | 250,000 | -345,000 | -58.0% | 2.15% | $4.1M | — |
As of 2021 Q3 — sorted by position size